The beneficial effect of high dose chemotherapy with HSCT in patients with advanced ovarian carcinoma, with complete clinical remission

Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 5

Abstract

Twenty-two patients with advanced ovarian carcinoma underwent high-dose chemotherapy supported by hematopoietic stem cell transplantation. Ten patients received double transplantation following ICE and CME, respectively. Twelve patients received only one course of high dose chemotherapy (CME, ICE, Melphalan and Carboplatine or Melphalan). Seven and 15 patients were in CR and PR prior to autologous HSCT, respectively. Toxicity was in a majority of cases manageable. One patient died due to infection complication after the second transplant. All patients were followed and their fate registered. It was shown that patients in clinical remission prior to HD chemotherapy enjoyed statistically significant better two years survival as compared to those with PR (83% vs 37%, p=0.049). The median follow-up of patients was 24.7 months in the CR group and 12.5 months in PR group. Overall cumulative proportion of survival was significantly better in the group with CR prior to the procedure. There was no difference in overall survival with respect to one or two HD chemotherapy courses and to length of the disease. The survival of patients with PR was unsatisfactory calling for a maintenance involving immunotherapy according to the recent progress in this field.

Authors and Affiliations

Andrzej Lange, Joanna Werkun, Dorota Dłubek, Cezary Juda, Marian Gryboś

Keywords

Related Articles

PSA bounce phenomenon after External Beam Radiation Therapy for prostate cancer.

Introduction to clinical practice of PSA antigen altered the therapeutic approach to treatment of prostate cancer. The PSA antigen was defined as sensitive marker for monitoring of prostate cancer. At treated with radio...

Przerzutowy rak embrionalny stercza u 19-letniego mężczyzny – przypadek kazuistyczny

Doniesienie o nieopisywanym w bazie danych medycznych MEDLINE przypadku raka zarodkowego jądra, dającego przerzut nowotworowy do stercza u 19-letniego mężczyzny. Pacjent został przyjęty w trybie pilnym na oddział urolog...

The effect of ionising radiation upon the cellular DNA

Ionising radiation applied in the therapy of tumour diseases, are inducing formation of various DNA damages. This can interact with DNA molecules and evoke alkaline ionisation and this is the direct effect or through rad...

Kliniczne znaczenie komplementarnych oznaczeń standardowych markerów nowotworowych i wybranych cytokin w surowicy krwi chorych na raka szyjki macicy

Celem pracy było określenie zależności pomiędzy stężeniami oznaczanych w surowicy krwi markerów nowotworowych (SCC, CEA, CA 125, CYFRY 21.1) i cytokin (IL-6, VEGF) a cechami kliniczno-patologicznymi oraz ocena ich komp...

Ocena jakości życia chorych leczonych chirurgicznie z powodu raka odbytnicy w aspekcie czynników społeczno-demograficznych

Cel: Celem pracy była ocena wpływu czynników społeczno-demograficznych na odległą jakość życia pacjentów, leczonych chirurgicznie z powodu raka odbytnicy metodą resekcji przedniej niskiej lub wycięcia brzuszno-kroczowe...

Download PDF file
  • EP ID EP159824
  • DOI -
  • Views 72
  • Downloads 0

How To Cite

Andrzej Lange, Joanna Werkun, Dorota Dłubek, Cezary Juda, Marian Gryboś (2006). The beneficial effect of high dose chemotherapy with HSCT in patients with advanced ovarian carcinoma, with complete clinical remission. Współczesna Onkologia, 10(5), 236-239. https://europub.co.uk/articles/-A-159824